Vistagen Therapeutics, Inc. (VTGN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-16
4:25 pm
Sale
2026-09-3013GVISTAGEN THERAPEUTICS INC
VTGN
BIOTECHNOLOGY VALUE FUND L P1,690,014
3.700%
-1,394,310decrease
(-45.21%)
Filing
History
2026-11-16
4:10 pm
Sale
2026-09-3013GVISTAGEN THERAPEUTICS INC
VTGN
Commodore Capital LP1,690,014
3.700%
-2,554,576decrease
(-60.18%)
Filing
History
2026-08-14
5:49 pm
Sale
2026-06-3013GVISTAGEN THERAPEUTICS INC
VTGN
OrbiMed Advisors LLC0
0.000%
-1,639,700decrease
(Position Closed)
Filing
History
2026-08-14
4:27 pm
Purchase
2026-06-3013GVISTAGEN THERAPEUTICS INC
VTGN
TCG Crossover GP I, LLC2,960,404
6.700%
2,960,404increase
(New Position)
Filing
History
2026-08-14
4:04 pm
Sale
2026-06-3013GVISTAGEN THERAPEUTICS INC
VTGN
Commodore Capital LP4,244,590
9.900%
-138,918decrease
(-3.17%)
Filing
History
2026-05-15
4:26 pm
Purchase
2026-03-3113GVISTAGEN THERAPEUTICS INC
VTGN
TCG Crossover GP II, LLC4,100,029
9.990%
1,397,872increase
(+51.73%)
Filing
History
2026-02-17
6:33 pm
Unchanged
2025-12-3113GVISTAGEN THERAPEUTICS INC
VTGN
OrbiMed Advisors LLC1,639,700
4.200%
0
(Unchanged)
Filing
History
2026-02-17
4:26 pm
Purchase
2025-12-3113GVISTAGEN THERAPEUTICS INC
VTGN
Commodore Capital LP4,383,508
9.900%
2,015,624increase
(+85.12%)
Filing
History
2026-02-17
4:16 pm
Unchanged
2025-12-3113GVISTAGEN THERAPEUTICS INC
VTGN
Great Point Partners, LLC2,055,834
4.950%
0
(Unchanged)
Filing
History
2026-02-17
12:35 pm
Sale
2025-12-3113GVISTAGEN THERAPEUTICS INC
VTGN
Janus Henderson Group Ltd.
JHG
0
0.000%
-4,165,767decrease
(Position Closed)
Filing
History
2026-02-17
10:02 am
Sale
2025-12-3113GVISTAGEN THERAPEUTICS INC
VTGN
StemPoint Capital LP616,749
1.500%
-1,711,743decrease
(-73.51%)
Filing
History
2026-02-13
5:08 pm
Sale
2025-12-3113GVISTAGEN THERAPEUTICS INC
VTGN
Nantahala Capital Management, LLC1,953,045
4.710%
-1,232,519decrease
(-38.69%)
Filing
History
2026-01-30
2:47 pm
Purchase
2025-12-3113GVISTAGEN THERAPEUTICS INC
VTGN
VANGUARD GROUP INC1,824,738
4.620%
137,003increase
(+8.12%)
Filing
History
2025-11-14
6:04 pm
Purchase
2025-09-3013GVISTAGEN THERAPEUTICS INC
VTGN
OrbiMed Advisors LLC1,639,700
5.340%
1,639,700increase
(New Position)
Filing
History
2025-11-14
4:37 pm
Purchase
2025-09-3013GVISTAGEN THERAPEUTICS INC
VTGN
Nantahala Capital Management, LLC3,185,564
9.990%
351,228increase
(+12.39%)
Filing
History
2025-11-14
3:18 pm
Unchanged
2025-09-3013GVISTAGEN THERAPEUTICS INC
VTGN
Great Point Partners, LLC2,055,834
6.280%
0
(Unchanged)
Filing
History
2025-10-31
11:41 am
Sale
2025-09-3013GVISTAGEN THERAPEUTICS INC
VTGN
VANGUARD GROUP INC1,687,735
5.500%
-146,777decrease
(-8.00%)
Filing
History
2025-09-08
1:07 pm
Purchase
2025-08-2913GVISTAGEN THERAPEUTICS INC
VTGN
Janus Henderson Group Ltd.
JHG
4,165,767
13.600%
4,165,767increase
(New Position)
Filing
History
2025-08-14
5:13 pm
Unchanged
2025-06-3013GVISTAGEN THERAPEUTICS INC
VTGN
Great Point Partners, LLC2,055,834
6.590%
0
(Unchanged)
Filing
History
2025-05-15
4:48 pm
Unchanged
2025-03-3113GVISTAGEN THERAPEUTICS INC
VTGN
Great Point Partners, LLC2,055,834
6.650%
0
(Unchanged)
Filing
History
Goto 0, 1, 2, Next